NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/31/2024
Back to search
Official data from USPTO
NOVORIG
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NOVORIG
ST13
US500000090112581Class
1, 5, 44
Filing
90112581
Registration
7629143
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
65
Latest update
12/31/2024
Trademark type
Word
Nice classes
1, 5, 44
Filing date
08/13/2020
Registration date
12/31/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/31/2024
Last transaction
12/31/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
03
Owner location
Kitchener, Ontario, CA
Examiner
ROSEN, BENJAMIN
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Rapid Novor Inc.
Representatives
Jeffrey B. Sladkus, Esq. The Sladkus Law Group
Technical classification
Nice Classes
Class 1Class 5Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Proteomics analysis test kits comprising reagents for detectingquantifying and characterizing antibody proteins in a biological sample for scientific research purposes
Class 5
Medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting cancerautoimmune diseases and infections
Class 44
Providing medical diagnostic and prognostic testing for cancerautoimmune diseases and infectionsthe medical analysisevaluationreporting of test results to help healthcare professionals determine a patient's clinical diagnosisthe effectiveness of treatmentsto revise future treatments accordingly; providing medical diagnostic and prognostic testing services; consulting services in the field of medical diagnostic testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories
Publications
History of USPTO decisions and trademark events.
65 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/31/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/12/2024
PUBO
PUBLISHED FOR OPPOSITION
11/12/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/23/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/22/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/22/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/20/2024
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
08/28/2024
GNSI
INQUIRY TO SUSPENSION E-MAILED
08/28/2024
CNSI
SUSPENSION INQUIRY WRITTEN
08/28/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/08/2023
GNSL
LETTER OF SUSPENSION E-MAILED
12/08/2023
CNSL
SUSPENSION LETTER WRITTEN
12/08/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/07/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/07/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
12/06/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
10/23/2023
GNSI
INQUIRY TO SUSPENSION E-MAILED
10/23/2023
CNSI
SUSPENSION INQUIRY WRITTEN
10/23/2023
DOCK
ASSIGNED TO EXAMINER
10/23/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
10/17/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/13/2023
GNSL
LETTER OF SUSPENSION E-MAILED
03/13/2023
CNSL
SUSPENSION LETTER WRITTEN
03/13/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/13/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/13/2023
ALIE
ASSIGNED TO LIE
03/10/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/03/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
12/16/2022
GNSI
INQUIRY TO SUSPENSION E-MAILED
12/16/2022
CNSI
SUSPENSION INQUIRY WRITTEN
12/16/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/01/2022
GNSL
LETTER OF SUSPENSION E-MAILED
06/01/2022
CNSL
SUSPENSION LETTER WRITTEN
06/01/2022
DMCC
DATA MODIFICATION COMPLETED
06/01/2022
DPCC
DIVISIONAL PROCESSING COMPLETE
05/31/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/31/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/03/2022
DRRR
DIVISIONAL REQUEST RECEIVED
05/03/2022
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
05/03/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
05/03/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
11/05/2021
GNSI
INQUIRY TO SUSPENSION E-MAILED
11/05/2021
CNSI
SUSPENSION INQUIRY WRITTEN
11/05/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/05/2021
GNSL
LETTER OF SUSPENSION E-MAILED
05/05/2021
CNSL
SUSPENSION LETTER WRITTEN
05/05/2021
DOCK
ASSIGNED TO EXAMINER
04/12/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/23/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/23/2021
ALIE
ASSIGNED TO LIE
03/18/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/16/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/14/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/14/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/14/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/14/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/14/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/14/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/08/2020
GNRT
NON-FINAL ACTION E-MAILED
12/08/2020
CNRT
NON-FINAL ACTION WRITTEN
12/08/2020
DOCK
ASSIGNED TO EXAMINER
12/08/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/17/2020
Continuous trademark protection
Get notified about every new filing that threatens NOVORIG or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.